Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytogenetics of bone sarcomas]

A M Vagner-Capodano1, D Poitout

  • 1Laboratoire de Cytologie oncologique, C.H.U. Timone, Marseille.

Chirurgie; Memoires De L'Academie De Chirurgie
|January 1, 1994
PubMed
Summary

Cytogenetic advancements aid in diagnosing Ewing sarcoma, a rare bone cancer in children. A specific translocation, t(11;12), serves as a key diagnostic marker for this small round cell tumor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human biological reactions at the interface between bone tissue and polymethylmethacrylate cement.

Journal of materials science. Materials in medicine·2004
Same author

Cytogenetic study of six cases of radiation-induced meningiomas.

Cancer genetics and cytogenetics·2001
Same author

[A composite bone tumor].

Annales de pathologie·2001
Same author

Photo quiz. Diagnosis: hydatid bone disease (cystic echinococcosis).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.

Cancer genetics and cytogenetics·2000
Same author

Cytogenetic study of 33 ependymomas.

Cancer genetics and cytogenetics·1999

Area of Science:

  • Bone tumor research
  • Cytogenetics
  • Molecular biology

Context:

  • Ewing sarcoma is a challenging diagnosis among small round cell tumors.
  • Advances in cytogenetics and molecular biology have improved bone tumor diagnostics.
  • Ewing sarcoma accounts for 6% of all bone tumors and primarily affects children and adolescents.

Purpose:

  • To highlight the diagnostic advancements in Ewing sarcoma.
  • To differentiate Ewing sarcoma from other small round cell tumors using cytogenetic markers.

Summary:

  • Cytogenetic examinations are crucial for distinguishing Ewing sarcoma from other small round cell tumors.
  • A specific chromosomal translocation, t(11;12) (q24;q12), is identified as a reliable marker for Ewing sarcoma.
  • This molecular marker aids in improving diagnostic accuracy and patient prognosis.

Impact:

  • Enhanced diagnostic capabilities for Ewing sarcoma.
  • Improved differentiation from other pediatric bone cancers.
  • Potential for more targeted and effective treatment strategies.

Related Experiment Videos